It is thought that neither semaglutide nor tirzepatide are very good ... The results have been published in the New England Journal of Medicine. Professors Wassilios Meissner and Olivier Rascol ...

Researchers from the Rutgers Robert Wood Johnson Medical School and the Children's Hospital of Orange County discovered a ...

ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Plozasiran Update On January 17, 2025, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) announced that the U.S. Food and Drug Administration (FDA) ...

If you continue to have this issue please contact [email protected]. Adults receiving tirzepatide in the SURPASS trials had significant decreases in urine albumin-to-creatinine ratio.

Eli Lilly’s diabetes and obesity therapy tirzepatide could find a use as a treatment for obstructive sleep apnoea (OSA) after hitting the mark in a pair of phase 3 trials. OSA is a prevalent ...

Eli Lilly's latest clinical readout for dual GIP/GLP-1 agonist tirzepatide is a big one, with data suggesting the drug can reduce the risk of developing type 2 diabetes in overweight and obese ...

The FDA has said it has agreed to reconsider its decision to prevent compounding pharmacies from producing and selling versions of Eli Lilly's diabetes and obesity drug tirzepatide. The US ...

The body of Sam Nordquist, 24, was found in a field after he had been reported missing. The district attorney in Ontario County, N.Y., called the circumstances surrounding the death “beyond ...

At the Munich Security Conference, Olaf Scholz accused the U.S. vice president of unacceptable interference in Germany’s coming elections. By Jim Tankersley and Andrew E. Kramer After years of ...

A proposed new law would release homeowners from the onerous process of listing every object lost in a destroyed home. By Rukmini Callimachi Through jobs, marriages and children, one guy has ...

Bret Taylor, the chairman of OpenAI’s board, said the artificial intelligence company was “not for sale.” Mr. Musk is separately raising money for his A.I. start-up, xAI. By Cade MetzMike ...

The US Food and Drug Administration (FDA) has declared an end to the shortage of tirzepatide, the active ingredient in Eli Lilly’s popular weight loss medication Zepbound and diabetes drug Mounjaro.